Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosisAtsushi Hayashi, Masahide Ohmichi, Akiko Tanabe et al.|Journal of Ovarian Research|2012Cited by 120
CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathwaysKiyoko Nakamura, Masahide Ohmichi, Yoshito Terai et al.|Oncology Reports|2017Cited by 117
Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancerYoshimichi Tanaka, Masahide Ohmichi, Yoshito Terai et al.|Cancer Biology & Therapy|2013Cited by 110
The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancerMasaaki Takai, Masahide Ohmichi, Yoshito Terai et al.|Journal of Ovarian Research|2014Cited by 108
GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancerSatoe Fujiwara, Masahide Ohmichi, Hiroshi Sasaki et al.|Journal of Ovarian Research|2012Cited by 79